AI assistant
Dolby Laboratories, Inc. — Director's Dealing 2026
Feb 9, 2026
30828_dirs_2026-02-09_6e4a488b-7e39-4431-87e4-7052274c947f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2026-02-05
Reporting Person: YEAMAN KEVIN J (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-05 | Employee Stock Option (Right to Buy) | $66.62 | G | 145252 | Disposed | 2035-12-15 | Class A Common Stock (145252) | Direct |
| 2026-02-05 | Employee Stock Option (Right to Buy) | $66.62 | G | 145252 | Acquired | 2035-12-15 | Class A Common Stock (145252) | Indirect |
Footnotes
F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5.
F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
F3: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009